Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001144204-15-066895
Filing Date
2015-11-19
Accepted
2015-11-19 12:40:08
Documents
1
Period of Report
2015-11-16

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT v425154_3.html 3  
1 OWNERSHIP DOCUMENT v425154_3.xml 3 2541
  Complete submission text file 0001144204-15-066895.txt   3889
Mailing Address 442 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 442 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080 650.243.3100
KALOBIOS PHARMACEUTICALS INC (Issuer) CIK: 0001293310 (see all company filings)

EIN.: 770557236 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 108-20 71ST AVE, APT PH2C FOREST HILLS NY 11375
Business Address
BIESTEK MAREK (Reporting) CIK: 0001658857 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35798 | Film No.: 151243092